# MACOM Technology Solutions Holdings, Inc.: financial statements, quarterly MTSI · Nasdaq · CIK 1493594 · [Technology](/sectors/technology.md) · fiscal year ends Oct 3 Pages: [Overview](/companies/mtsi.md) · [Financials](/companies/mtsi/financials.md) · [Filings](/companies/mtsi/filings.md) · [Insiders](/companies/mtsi/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtsi/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2025-01-03) | Q2 FY2025 (2025-04-04) | Q3 FY2025 (2025-07-04) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [150 d](/filings/0001493594-25-000054.md) | [157](/filings/0001493594-25-000020.md) | [181](/filings/0001493594-25-000029.md) | [190](/filings/0001493594-25-000038.md) | [201 d](/filings/0001493594-25-000054.md) | [218](/filings/0001493594-26-000019.md) | [236](/filings/0001493594-26-000028.md) | [252](/filings/0001493594-26-000038.md) | [261 d](/filings/0001493594-25-000054.md) | [272](/filings/0001493594-26-000019.md) | [289](/filings/0001493594-26-000028.md) | [342](/filings/0001493594-26-000038.md) | | Cost of revenue | $m | [63.7 d](/filings/0001493594-25-000054.md) | [69.8](/filings/0001493594-25-000020.md) | [86.0](/filings/0001493594-25-000029.md) | [89.1](/filings/0001493594-25-000038.md) | [90.9 d](/filings/0001493594-25-000054.md) | [101](/filings/0001493594-26-000019.md) | [106](/filings/0001493594-26-000028.md) | [113](/filings/0001493594-26-000038.md) | [119 d](/filings/0001493594-25-000054.md) | [120](/filings/0001493594-26-000019.md) | [125](/filings/0001493594-26-000028.md) | [143](/filings/0001493594-26-000038.md) | | Gross profit | $m | [86.6 d](/filings/0001493594-25-000054.md) | [87.3](/filings/0001493594-25-000020.md) | [95.2](/filings/0001493594-25-000029.md) | [101](/filings/0001493594-25-000038.md) | [110 d](/filings/0001493594-25-000054.md) | [117](/filings/0001493594-26-000019.md) | [130](/filings/0001493594-26-000028.md) | [139](/filings/0001493594-26-000038.md) | [142 d](/filings/0001493594-25-000054.md) | [152](/filings/0001493594-26-000019.md) | [164](/filings/0001493594-26-000028.md) | [200](/filings/0001493594-26-000038.md) | | Research and development | $m | [37.5 d](/filings/0001493594-25-000054.md) | [39.4](/filings/0001493594-25-000020.md) | [45.6](/filings/0001493594-25-000029.md) | [47.5](/filings/0001493594-25-000038.md) | [49.6 d](/filings/0001493594-25-000054.md) | [60.4](/filings/0001493594-26-000019.md) | [57.8](/filings/0001493594-26-000028.md) | [63.4](/filings/0001493594-26-000038.md) | [62.9 d](/filings/0001493594-25-000054.md) | [66.5](/filings/0001493594-26-000019.md) | [69.0](/filings/0001493594-26-000028.md) | [74.3](/filings/0001493594-26-000038.md) | | Selling, general and administrative | $m | [33.5 d](/filings/0001493594-25-000054.md) | [36.9](/filings/0001493594-25-000020.md) | [34.2](/filings/0001493594-25-000029.md) | [34.2](/filings/0001493594-25-000038.md) | [32.7 d](/filings/0001493594-25-000054.md) | [39.2](/filings/0001493594-26-000019.md) | [37.4](/filings/0001493594-26-000028.md) | [38.4](/filings/0001493594-26-000038.md) | [39.8 d](/filings/0001493594-25-000054.md) | [42.0](/filings/0001493594-26-000019.md) | [44.6](/filings/0001493594-26-000028.md) | [48.1](/filings/0001493594-26-000038.md) | | Operating income | $m | [15.6 d](/filings/0001493594-25-000054.md) | [11.0](/filings/0001493594-25-000020.md) | [15.4](/filings/0001493594-25-000029.md) | [19.7](/filings/0001493594-25-000038.md) | [27.5 d](/filings/0001493594-25-000054.md) | [17.5](/filings/0001493594-26-000019.md) | [34.9](/filings/0001493594-26-000028.md) | [37.7](/filings/0001493594-26-000038.md) | [39.6 d](/filings/0001493594-25-000054.md) | [43.3](/filings/0001493594-26-000019.md) | [50.8](/filings/0001493594-26-000028.md) | [77.1](/filings/0001493594-26-000038.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(5.5) d](/filings/0001493594-25-000054.md) | [2.8](/filings/0001493594-25-000020.md) | [4.5](/filings/0001493594-25-000029.md) | [4.3](/filings/0001493594-25-000038.md) | [3.1 d](/filings/0001493594-25-000054.md) | [(2.4)](/filings/0001493594-26-000019.md) | [9.3](/filings/0001493594-26-000028.md) | [7.5](/filings/0001493594-26-000038.md) | [10.8 d](/filings/0001493594-25-000054.md) | [0.8](/filings/0001493594-26-000019.md) | [10.6](/filings/0001493594-26-000028.md) | [23.1](/filings/0001493594-26-000038.md) | | Net income | $m | [24.5 d](/filings/0001493594-25-000054.md) | [12.5](/filings/0001493594-25-000020.md) | [15.0](/filings/0001493594-25-000029.md) | [19.9](/filings/0001493594-25-000038.md) | [29.4 d](/filings/0001493594-25-000054.md) | [(168)](/filings/0001493594-26-000019.md) | [31.7](/filings/0001493594-26-000028.md) | [36.5](/filings/0001493594-26-000038.md) | [45.1 d](/filings/0001493594-25-000054.md) | [48.8](/filings/0001493594-26-000019.md) | [46.3](/filings/0001493594-26-000028.md) | [101](/filings/0001493594-26-000038.md) | | Diluted EPS | $ per share | not reported | [0.17](/filings/0001493594-25-000020.md) | [0.20](/filings/0001493594-25-000029.md) | [0.27](/filings/0001493594-25-000038.md) | not reported | [(2.30)](/filings/0001493594-26-000019.md) | [0.42](/filings/0001493594-26-000028.md) | [0.48](/filings/0001493594-26-000038.md) | not reported | [0.64](/filings/0001493594-26-000019.md) | [0.60](/filings/0001493594-26-000028.md) | [1.28](/filings/0001493594-26-000038.md) | | Basic EPS | $ per share | not reported | [0.18](/filings/0001493594-25-000020.md) | [0.21](/filings/0001493594-25-000029.md) | [0.28](/filings/0001493594-25-000038.md) | not reported | [(2.30)](/filings/0001493594-26-000019.md) | [0.43](/filings/0001493594-26-000028.md) | [0.49](/filings/0001493594-26-000038.md) | not reported | [0.65](/filings/0001493594-26-000019.md) | [0.62](/filings/0001493594-26-000028.md) | [1.32](/filings/0001493594-26-000038.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | FY2024 (2024-09-27) | Q1 FY2025 (2025-01-03) | Q2 FY2025 (2025-04-04) | Q3 FY2025 (2025-07-04) | FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [174](/filings/0001493594-24-000060.md) | [164](/filings/0001493594-24-000028.md) | [115](/filings/0001493594-24-000040.md) | [117](/filings/0001493594-24-000052.md) | [147](/filings/0001493594-25-000054.md) | [233](/filings/0001493594-25-000020.md) | [111](/filings/0001493594-25-000029.md) | [125](/filings/0001493594-25-000038.md) | [112](/filings/0001493594-26-000038.md) | [120](/filings/0001493594-26-000019.md) | [98.5](/filings/0001493594-26-000028.md) | [89.6](/filings/0001493594-26-000038.md) | | Current assets | $m | [761](/filings/0001493594-24-000060.md) | [745](/filings/0001493594-24-000028.md) | [798](/filings/0001493594-24-000040.md) | [844](/filings/0001493594-24-000052.md) | [903](/filings/0001493594-25-000054.md) | [982](/filings/0001493594-25-000020.md) | [1,064](/filings/0001493594-25-000029.md) | [1,127](/filings/0001493594-25-000038.md) | [1,205](/filings/0001493594-26-000038.md) | [1,206](/filings/0001493594-26-000019.md) | [1,126](/filings/0001493594-26-000028.md) | [1,172](/filings/0001493594-26-000038.md) | | Total assets | $m | [1,553](/filings/0001493594-24-000060.md) | [1,651](/filings/0001493594-24-000028.md) | [1,676](/filings/0001493594-24-000040.md) | [1,705](/filings/0001493594-24-000052.md) | [1,756](/filings/0001493594-25-000054.md) | [1,844](/filings/0001493594-25-000020.md) | [1,919](/filings/0001493594-25-000029.md) | [2,003](/filings/0001493594-25-000038.md) | [2,103](/filings/0001493594-26-000038.md) | [2,106](/filings/0001493594-26-000019.md) | [2,015](/filings/0001493594-26-000028.md) | [2,147](/filings/0001493594-26-000038.md) | | Current liabilities | $m | [83.5](/filings/0001493594-24-000060.md) | [103](/filings/0001493594-24-000028.md) | [109](/filings/0001493594-24-000040.md) | [103](/filings/0001493594-24-000052.md) | [108](/filings/0001493594-25-000054.md) | [272](/filings/0001493594-25-000020.md) | [299](/filings/0001493594-25-000029.md) | [295](/filings/0001493594-25-000038.md) | [325](/filings/0001493594-26-000038.md) | [305](/filings/0001493594-26-000019.md) | [150](/filings/0001493594-26-000028.md) | [502](/filings/0001493594-26-000038.md) | | Total liabilities | $m | [606](/filings/0001493594-24-000060.md) | [627](/filings/0001493594-24-000028.md) | [631](/filings/0001493594-24-000040.md) | [624](/filings/0001493594-24-000052.md) | [629](/filings/0001493594-25-000054.md) | [693](/filings/0001493594-25-000020.md) | [717](/filings/0001493594-25-000029.md) | [740](/filings/0001493594-25-000038.md) | [776](/filings/0001493594-26-000038.md) | [752](/filings/0001493594-26-000019.md) | [597](/filings/0001493594-26-000028.md) | [606](/filings/0001493594-26-000038.md) | | Long-term debt | $m | [447](/filings/0001493594-24-000060.md) | [447](/filings/0001493594-24-000028.md) | [448](/filings/0001493594-24-000040.md) | [448](/filings/0001493594-24-000052.md) | [448](/filings/0001493594-25-000054.md) | [339](/filings/0001493594-25-000020.md) | [339](/filings/0001493594-25-000029.md) | [339](/filings/0001493594-25-000038.md) | [340](/filings/0001493594-26-000038.md) | [340](/filings/0001493594-26-000019.md) | [340](/filings/0001493594-26-000028.md) | [0.0](/filings/0001493594-26-000038.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001493594-25-000054.md) | [161](/filings/0001493594-25-000020.md) | [161](/filings/0001493594-25-000029.md) | [161](/filings/0001493594-25-000038.md) | [161](/filings/0001493594-26-000038.md) | [161](/filings/0001493594-26-000019.md) | [0.0](/filings/0001493594-26-000028.md) | [340](/filings/0001493594-26-000038.md) | | Shareholders' equity | $m | [948](/filings/0001493594-25-000054.md) | [1,024](/filings/0001493594-25-000029.md) | [1,046](/filings/0001493594-25-000038.md) | [1,081](/filings/0001493594-25-000038.md) | [1,126](/filings/0001493594-26-000038.md) | [1,151](/filings/0001493594-26-000028.md) | [1,202](/filings/0001493594-26-000038.md) | [1,263](/filings/0001493594-26-000038.md) | [1,327](/filings/0001493594-26-000038.md) | [1,353](/filings/0001493594-26-000028.md) | [1,418](/filings/0001493594-26-000038.md) | [1,541](/filings/0001493594-26-000038.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2025-01-03) | Q2 FY2025 (2025-04-04) | Q3 FY2025 (2025-07-04) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [50.4 d](/filings/0001493594-25-000054.md) | [33.1](/filings/0001493594-25-000020.md) | [18.2 d](/filings/0001493594-25-000029.md) | [49.0 d](/filings/0001493594-25-000038.md) | [62.3 d](/filings/0001493594-25-000054.md) | [66.7](/filings/0001493594-26-000019.md) | [38.7 d](/filings/0001493594-26-000028.md) | [60.4 d](/filings/0001493594-26-000038.md) | [69.6 d](/filings/0001493594-25-000054.md) | [42.9](/filings/0001493594-26-000019.md) | [78.7 d](/filings/0001493594-26-000028.md) | [80.0 d](/filings/0001493594-26-000038.md) | | Capital expenditure | $m | [5.8 d](/filings/0001493594-25-000054.md) | [4.7](/filings/0001493594-25-000020.md) | [5.1 d](/filings/0001493594-25-000029.md) | [7.5 d](/filings/0001493594-25-000038.md) | [5.2 d](/filings/0001493594-25-000054.md) | [5.3](/filings/0001493594-26-000019.md) | [8.2 d](/filings/0001493594-26-000028.md) | [8.8 d](/filings/0001493594-26-000038.md) | [20.2 d](/filings/0001493594-25-000054.md) | [12.9](/filings/0001493594-26-000019.md) | [13.2 d](/filings/0001493594-26-000028.md) | [20.8 d](/filings/0001493594-26-000038.md) | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [0.1 d](/filings/0001493594-25-000054.md) | [11.6](/filings/0001493594-25-000020.md) | [1.0 d](/filings/0001493594-25-000029.md) | [1.4 d](/filings/0001493594-25-000038.md) | [0.3 d](/filings/0001493594-25-000054.md) | [37.9](/filings/0001493594-26-000019.md) | [3.4 d](/filings/0001493594-25-000029.md) | [1.4 d](/filings/0001493594-25-000038.md) | [0.5 d](/filings/0001493594-25-000054.md) | [47.9](/filings/0001493594-26-000019.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-12-30) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q1 FY2025 (2025-01-03) | Q2 FY2025 (2025-04-04) | Q3 FY2025 (2025-07-04) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [71.4](/filings/0001493594-24-000028.md) | [71.4](/filings/0001493594-24-000040.md) | [71.4](/filings/0001493594-24-000052.md) | [72.3](/filings/0001493594-25-000020.md) | [73.3](/filings/0001493594-25-000029.md) | [74.2](/filings/0001493594-25-000038.md) | [72.8](/filings/0001493594-26-000019.md) | [75.7](/filings/0001493594-26-000028.md) | [75.9](/filings/0001493594-26-000038.md) | [76.7](/filings/0001493594-26-000019.md) | [77.6](/filings/0001493594-26-000028.md) | [78.4](/filings/0001493594-26-000038.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 76,370,931 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001493594-26-000038.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.